The Discounted Cash Flow (DCF) valuation of ABIOMED Inc (ABMD) is 135.72 USD. With the latest stock price at 381.02 USD, the upside of ABIOMED Inc based on DCF is -64.4%.
Based on the latest price of 381.02 USD and our DCF valuation, ABIOMED Inc (ABMD) is a sell. selling Abiomed stocks now will result in a potential gain of 64.4%.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 7.3% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 84.82 - 394.13 | 135.72 |
| Upside | -77.7% - 3.4% | -64.4% |